The article reports on the development of a low-cost, user-friendly point-of-care (POC) device capable of detecting severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and several variants in an hour using saliva samples by researchers at Harvard Wyss Institute for Biologically Inspired Engineering in 2021.